All In MedTech

Device Trial Radar · NCT02890303

A Prospective Multi-Center Study of Anterior Lens Capsulotomy Using the Mynosys Zepto System

Last checked: Nov 20, 2026Latest source record: Apr 27, 2018 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

100

Actual

Start

Sep 12, 2016

Primary completion

Dec 15, 2016

Study completion Mar 14, 2017

Sponsor

Lead sponsor
Mynosys Cellular Devices, Inc.Not on our public-company list
Sponsor type
Industry
First posted
Sep 7, 2016

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 22 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study will evaluate outcome in subjects who have elected to have Zepto capsulotomies during cataract surgery with phacoemulsification.

Conditions

  • Cataract

Interventions

  • Zepto SystemDevice

    Anterior Capsulotomy using the Zepto System.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Complete CapsulotomyTime frame: During surgery

Locations

No sites are listed on the registry yet.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.